From the moment you turn off your morning alarm, to the time you hit the pillow, your life is full of surfaces. Swiping through your phone, opening doors, putting in your PIN – there are many you don’t think twice about touching.
But SARS-CoV-2, the virus that causes COVID-19, will likely change the way we all think about, and interact with, surfaces forever. Our peer-reviewed study published in Virology Journal reveals new information about the virus and how it behaves on surfaces.
Understanding SARS-CoV-2 on surfaces
From analysing sewage to testing face masks, our research has been contributing to the global battle against COVID-19.
At this stage of the pandemic, researchers do not fully understand the role contaminated surfaces play in the transmission of SARS-CoV-2. To improve our understanding of how this new virus behaves, our researchers studied the survival rates of infectious SARS-CoV-2, dried in an artificial mucous solution, on six common surfaces.
We conducted the experiment at three different temperatures, 200C, 300C and 400C, with the relative humidity kept at 50 per cent. The surfaces used in the study were stainless steel, glass, vinyl, paper and polymer banknotes, and cotton cloth. These are examples of high contact surface areas such as glass on touchscreens and stainless steel doorknobs.
A droplet of fluid containing the virus at concentrations similar to levels observed in infected patients was dried on multiple small test surfaces and left for up to 28 days. At various time periods, the virus was recovered and placed in tissue culture cells to observe if any infectious virus remained.
Impact of temperature on virus
At 20°C, the virus was extremely robust. We were able to recover infectious material after 28 days from the smooth (non-porous) surfaces. These are stainless steel, glass, vinyl and paper and polymer banknotes.
The length of time infectious virus was able to survive on the porous material (cotton cloth) was much shorter. On cloth, we were unable to detect any viable virus past 14 days.
At 30°C infectious virus did not survive beyond seven days on stainless steel, money (polymer banknotes) and glass. However, on vinyl and cotton cloth, infectious material was not detectable beyond three days.
At 40°C virus was inactivated much faster. Infectious SARS-CoV-2 was detectable for less than 16 hours for cotton cloth. While on glass, paper and polymer notes, and stainless steel it was detectable for up to 24 hours, and 48 hours for vinyl.
Infographic explaining COVID-19 on surfaces.
How long SARS-CoV-2 survived on five different surfaces at three temperatures, 20°C, 30°C and 40°C.
How many particles can cause an infection?
It generally takes more than one virus particle to infect a person and make them sick. We call the number of virus particles that can cause infection the “infectious dose”. This dosage differs between different viruses and is usually quite large.
Researchers do not yet know the infectious dose of SARS-CoV-2. But, from our knowledge of related viruses, we estimate it is around 300 particles. If the virus was placed (on smooth surfaces) at standard mucus concentrations of an infected person, enough virus would easily survive for two weeks to be able to infect another person.
Further research on this topic is necessary. However, our findings indicate the 28-day sample would not contain enough viable virus to infect a person.
Whether virus particles on a surface can infect someone is dependent on several conditions. Outside of the body, SARS-CoV-2 virus particles gradually become inactive over time. The time it takes for viruses to naturally inactivate depends on many factors. The makeup of the virus itself, the type of surface it is on and whether the virus is liquid or dried can impact the time it remains viable. Environmental conditions such as temperature, exposure to sunlight and humidity also play a part.
Image Credit: Australian Centre for Disease Preparedness (ACDP)
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]
In a recent study conducted at the Baylor College of Medicine, Houston, USA, scientists have identified six vaccine breakthrough cases caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A [...]
A new Covid-19 strain that is much more dangerous than the Delta variant has been detected in more than 30 countries in the past four weeks, says the Health Ministry. "The Lambda strain was [...]
Weakened lungs and immune systems make people increasingly vulnerable, warn scientists. A rash of cases of a rare “black fungus” infection affecting thousands of critically ill Covid patients in India caused alarm last month. [...]
Using real-time deformability cytometry, researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen were able to show for the first time: COVID-19 significantly changes the size and stiffness of red and white blood [...]